Home › BIO Joins AdvaMed, PhRMA in Letter Expressing Concerns with Sunshine Act Implementation
 

Keywords :   


BIO Joins AdvaMed, PhRMA in Letter Expressing Concerns with Sunshine Act Implementation

2014-09-22 06:00:00| Industrial Newsroom - All News for Today

BIO President and CEO James Greenwood joined AdvaMed President and CEO Stephen Ubl and PhRMA President and CEO John Castellani in letter to CMS Administrator Marilyn Tavenner highlighting ongoing concerns about potential lack of necessary context around Sunshine data release. Physician Payments Sunshine Act, section 6002 of Affordable Care Act of 2010, will provide transparency in industry collaboration with teaching hospitals, physicians; and report physician ownership and investment ...This story is related to the following:Trade Associations

Tags: act letter concerns implementation

Category:Industrial Goods and Services

Latest from this category

All news
15.05Relationship Reviews Strengthening the Partnership Between Manufacturer and Rep
14.05Consolidated Financial Statements for the twelve-month period ended March 31, 2024
14.05Actions to Implement Management that is Conscious of Cost of Capital and Stock Price
Industrial Goods and Services »
17.05Is China's bubble tea bubble about to burst?
17.05Eastern North Pacific Tropical Weather Outlook
17.05Atlantic Tropical Weather Outlook
17.05Business locked in expensive AI 'arms race'
17.05Is the move to electric cars running out of power?
17.05Pornhub partners with UK child abuse fighting charity
16.05CFTC charges Agridime and its co-founders with a fraudulent cattle scheme
16.05Baleage: Advantageous for first cutting hay
More »